How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
Multiple myeloma (MM) is a B-cell malignancy characterized by clonal proliferation of malignant plasma cells in the bone marrow, monoclonal protein production in the serum, and organ dysfunction. It is part of a disease spectrum called plasma cell disorders, and to establish the diagnosis, a bone ma...
Saved in:
| Main Authors: | Wulyo Rajabto, Dimas Priantono |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2022-09-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/2029 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
by: Sikander Ailawadhi, et al.
Published: (2023-02-01) -
Can you diagnose immune thrombocytopenia in myeloma? A case of thrombocytopenia in a patient with multiple myeloma
by: Cláudia Diogo, et al.
Published: (2024-11-01) -
The characteristics of Korean elderly multiple myeloma patients aged 80 years or over
by: Sang Hwan Lee, et al.
Published: (2025-01-01) -
Enhancing prognosis in multiple myeloma bone disease: insights from a retrospective analysis of surgical interventions
by: Xiangjun Shi, et al.
Published: (2024-12-01) -
Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
by: Wen‐Ying Lin, et al.
Published: (2023-02-01)